Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 7,599,078 9.400% | -1,455,151 (-16.07%) | Filing History |
| 2024-11-12 3:48 pm Unchanged | 2024-09-30 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 9,703,237 11.780% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:47 am Purchase | 2024-09-30 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 9,703,237 11.780% | 1,325,570 (+15.82%) | Filing History |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 8,377,667 10.090% | 45,970 (+0.55%) | Filing History |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 9,054,229 10.900% | 551,348 (+6.48%) | Filing History |
| 2023-12-08 4:16 pm Purchase | 2023-11-30 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 8,331,697 10.030% | 199,218 (+2.45%) | Filing History |
| 2023-02-14 4:03 pm Unchanged | 2022-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | Fundsmith LLP | 4,447,828 5.370% | 0 (Unchanged) | Filing History |
| 2023-02-14 11:59 am Purchase | 2022-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | Fundsmith LLP | 4,447,828 5.370% | 221,400 (+5.24%) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 8,132,479 9.820% | 209,013 (+2.64%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,502,881 10.300% | 0 (Unchanged) | Filing History |
| 2023-01-20 3:00 pm Sale | 2022-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,502,881 10.300% | -487,705 (-5.42%) | Filing History |
| 2022-02-10 08:17 am Sale | 2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 7,923,466 9.340% | -1,181,793 (-12.98%) | Filing History |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,990,586 10.600% | 0 (Unchanged) | Filing History |
| 2022-01-25 3:03 pm Purchase | 2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,990,586 10.600% | 378,181 (+4.39%) | Filing History |
| 2021-09-09 4:20 pm Purchase | 2021-08-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,612,405 10.100% | 722,813 (+9.16%) | Filing History |
| 2021-02-12 12:27 pm Sale | 2020-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | Fundsmith LLP | 4,226,428 4.950% | -365,471 (-7.96%) | Filing History |
| 2021-02-10 11:03 am Sale | 2020-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 9,105,259 10.670% | -344,559 (-3.65%) | Filing History |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 7,889,592 9.200% | 464,747 (+6.26%) | Filing History |